Discovering innovative cancer therapies

From initial concept to the delivery of candidate drugs - we're a drug discovery company specialising in cutting-edge treatments for diseases with an unmet need

Learn about us

More than 10 years of experience in advancing novel concepts to candidate drug selection

Our track record of excellence means that we partner with some of the world's most innovative and established biotechnology and pharmaceutical companies.

Learn more about partnering

An extensive pipeline of R&D programmes

From concept to the delivery of candidate drugs, Sentinel Oncology is developing a portfolio of new therapies and is committed to improving the treatment options for patients

View our pipeline

"It's our vision to develop oncology drugs that are devoid of the systemic toxicities often associated with chemotherapeutics"

Bob Boyle, Chief Executive Officer & Founder
Meet the team & board